Guardant Health Inc.

NASDAQ: GH · Real-Time Price · USD
59.36
-1.00 (-1.66%)
At close: Aug 15, 2025, 1:28 PM

Guardant Health Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-436.37M -479.45M -654.59M -384.77M
Depreciation & Amortization
42.39M 42.88M 35.96M 22.27M
Stock-Based Compensation
140.41M 90.76M 94.69M 151.45M
Other Working Capital
-30.34M 55.81M 21.79M 3.2M
Other Non-Cash Items
74.58M -33.01M 152.91M 42.5M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-60.86M 53.84M 61.56M -40.47M
Operating Cash Flow
-239.86M -324.98M -309.46M -209.02M
Capital Expenditures
-35.09M -20.49M -77.46M -75.03M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-314.82M -635.5M -327.72M -940.23M
Sales Maturities Of Investments
88.6M 1.5B 555M 952.11M
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-261.31M 840.25M 149.82M -63.16M
Debt Repayment
n/a n/a -71K -146K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-996K -15.74M -189.02M -66.68M
Financial Cash Flow
-996K 477.38M -189.09M -66.82M
Net Cash Flow
-503.93M 991.74M -350.34M -340.69M
Free Cash Flow
-274.94M -345.46M -386.92M -284.05M